🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 14 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/06/2016 | 71,75 | 71,77 | 70,42 | 71,11 | -0,80% | 1,87% | 370.774 |
| 20/06/2016 | 70,95 | 72,14 | 70,83 | 71,68 | +2,24% | 1,85% | 569.546 |
| 17/06/2016 | 72,40 | 72,40 | 69,56 | 70,11 | -2,90% | 3,93% | 825.705 |
| 16/06/2016 | 71,62 | 72,63 | 71,04 | 72,21 | +0,70% | 2,23% | 444.191 |
| 15/06/2016 | 72,68 | 73,10 | 71,45 | 71,71 | -0,61% | 2,27% | 450.924 |
| 14/06/2016 | 70,29 | 72,41 | 69,96 | 72,15 | +2,29% | 3,48% | 533.639 |
| 13/06/2016 | 70,50 | 71,85 | 70,34 | 70,53 | -0,60% | 2,13% | 351.538 |
| 10/06/2016 | 71,02 | 71,47 | 70,29 | 70,95 | -1,16% | 1,66% | 567.302 |
| 09/06/2016 | 73,67 | 74,29 | 71,69 | 71,79 | -2,75% | 3,52% | 272.831 |
| 08/06/2016 | 72,25 | 74,17 | 71,77 | 73,82 | +2,66% | 3,33% | 462.786 |
| 07/06/2016 | 72,45 | 72,51 | 70,65 | 71,91 | -1,23% | 2,57% | 646.971 |
| 06/06/2016 | 73,73 | 73,76 | 70,46 | 72,81 | -1,15% | 4,47% | 505.586 |
| 03/06/2016 | 74,09 | 74,29 | 72,09 | 73,66 | -0,91% | 2,96% | 424.955 |
| 02/06/2016 | 73,13 | 75,27 | 73,04 | 74,34 | +1,15% | 3,05% | 492.281 |
| 01/06/2016 | 74,24 | 74,40 | 72,40 | 73,49 | -1,50% | 2,71% | 721.991 |
| 31/05/2016 | 77,10 | 77,92 | 74,17 | 74,60 | -2,62% | 4,86% | 643.765 |
| 27/05/2016 | 75,81 | 76,68 | 75,16 | 76,61 | +0,70% | 2,01% | 382.476 |
| 26/05/2016 | 76,53 | 76,96 | 75,50 | 76,08 | -0,49% | 1,91% | 365.965 |
| 25/05/2016 | 75,66 | 77,40 | 75,14 | 76,46 | +1,50% | 2,98% | 598.079 |
| 24/05/2016 | 74,76 | 75,66 | 74,29 | 75,33 | +1,22% | 1,84% | 522.899 |
| 23/05/2016 | 73,79 | 75,13 | 73,62 | 74,42 | +1,10% | 2,04% | 579.805 |
| 20/05/2016 | 73,47 | 74,50 | 72,33 | 73,61 | +0,71% | 2,95% | 449.161 |
| 19/05/2016 | 74,60 | 75,67 | 71,60 | 73,09 | -2,63% | 5,46% | 465.832 |
| 18/05/2016 | 73,52 | 75,75 | 73,52 | 75,07 | +1,46% | 3,03% | 477.854 |
| 17/05/2016 | 74,54 | 74,86 | 73,25 | 73,99 | -0,89% | 2,16% | 500.617 |
| 16/05/2016 | 73,49 | 75,41 | 73,21 | 74,65 | +1,93% | 2,99% | 648.093 |
| 13/05/2016 | 72,45 | 73,90 | 72,26 | 73,23 | +0,66% | 2,26% | 394.659 |
| 12/05/2016 | 72,94 | 73,44 | 71,45 | 72,75 | +0,21% | 2,72% | 803.424 |
| 11/05/2016 | 74,37 | 74,69 | 72,46 | 72,60 | -2,40% | 3,00% | 415.658 |
| 10/05/2016 | 75,98 | 76,46 | 73,61 | 74,38 | -1,91% | 3,74% | 495.648 |